When the U.S. began distributing COVID-19 vaccines this winter, Jordan Tralins ’23 found it odd that her social media feeds didn’t have any factual information about the shots. Tralins decided to do something about it.
On Aug. 16, the Class of 2026 received their short white coats during a Weill Cornell Medicine ceremony, officially marking the beginning of their medical educations.
The funding will support preliminary disease-related research, in the latest in a series of efforts to create new opportunities for interdisciplinary research.
Researchers at Weill Cornell Medicine have identified significant differences in the molecular characteristics of tumors from younger and older cancer patients across several cancer types.
What can faculty, students and community members be doing in response to institutional racism and its role in shaping health equity? A webinar organized by the Cornell Center for Health Equity will examine this question.
Anti-Mullerian hormone, traditionally thought of as a passive byproduct of polycystic ovary syndrome, may actually play an active role in the disorder, according to new research.
For physician and epidemiologist Dr. Jay Varma, the COVID-19 pandemic underscores not only the importance of public health, but also the powerful and pressing role of governments, academic medical centers and other organizations to work together on emerging health threats.
Researchers from Weill Cornell Medicine sampled gut bacteria from healthy fecal microbiota transplantation donors and from recipients with ulcerative colitis, identifying the bacterial strains that correlates with effective treatment.
Cornell Atkinson is soliciting nominations for The Earthshot Prize, a new global award supported by The Duke and Duchess of Cambridge to tackle the world’s biggest environmental challenges.
